Full Text View
Tabular View
No Study Results Posted
Related Studies
Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions
This study has been completed.
Study NCT00653055   Information provided by Par Pharmaceutical, Inc.
First Received: April 1, 2008   Last Updated: April 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Interventions listed in this trial
Cabergoline
Dostinex
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antineoplastic Agents
Antiparkinson Agents
Central Nervous System Agents
Dopamine Agents
Dopamine Agonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Par Pharmaceutical, Inc.
Anapharm


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services